Overview of Transaction

• On August 22, 2024, U.S. Bank, lead bank of U.S. Bancorp (NYSE: USB), announced it acquired Salucro Healthcare Solutions LLC
• Founded in 2004, Salucro is a market leader in providing online billing and payments offerings for healthcare providers across the United States
• Salucro had previously been a partner of Elavon, the merchant acquiring unit within U.S. Bank
• U.S. Bank initially invested in Salucro in 2022, and Salucro's platform is sold through Elavon, branded as MedEpay
• U.S. Bancorp serves millions of customers locally, nationally and globally through a diversified mix of businesses including consumer banking, business banking, commercial banking, institutional banking, payments and wealth management
• U.S. Bank provides a broad range of banking and payment services to healthcare organizations, including hospital systems, insurers, medical equipment manufacturers and medical, dental, and veterinary practices

Significance of Transaction

• This acquisition builds on U.S. Bank’s service to healthcare-focused clients
• Salucro’s robust billing and payment platform is an ideal complement to offerings from both U.S. Bank and Elavon

FT Partners' Role

• FT Partners served as the exclusive financial and strategic advisor to Salucro
• This transaction highlights FT Partners’ deep domain expertise in the Healthcare and Payments sectors, along with our successful track record generating highly favorable outcomes for FinTech companies